K210265 is an FDA 510(k) clearance for the VS3 Iridium Sytem. This device is classified as a Confocal Optical Imaging (Class II - Special Controls, product code OWN).
Submitted by Visionsense, Ltd. (Petach Tikva, Hamerkaz, IL). The FDA issued a Cleared decision on November 22, 2021, 294 days after receiving the submission on February 1, 2021.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 876.1500. Collection Of Light Signals For Visualization Of Cellular Microstructures..